Congenital rubella syndrome secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Dima Nimri (talk | contribs) |
Dima Nimri (talk | contribs) |
||
Line 9: | Line 9: | ||
*All hospital contacts and caregivers of [[infant]] with congenital rubella syndrome should be ensured that they are [[immune]] to [[rubella virus]] | *All hospital contacts and caregivers of [[infant]] with congenital rubella syndrome should be ensured that they are [[immune]] to [[rubella virus]] | ||
*Because [[infants]] with congenital rubella syndrome are infectious for at least a period of 12 months, they may pose a risk for unimmunized children and [[pregnant]] women | *Because [[infants]] with congenital rubella syndrome are infectious for at least a period of 12 months, they may pose a risk for unimmunized children and [[pregnant]] women | ||
*Seronegative women should be offered the [[MMR]] [[vaccine]] in the [[postpartum]] period to reduce the risk of [[rubella]] infection and congenital rubella syndrome in subsequent pregnancies.<ref name="pmid9639369">{{cite journal |vauthors=Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L |title=Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP) |journal=MMWR Recomm Rep |volume=47 |issue=RR-8 |pages=1–57 |year=1998 |pmid=9639369 |doi= |url=}}</ref> | |||
==References== | ==References== |
Revision as of 21:10, 17 January 2017
Congenital Rubella Syndrome Microchapters |
Differentiating Congenital Rubella Syndrome from other Diseases |
Diagnosis |
Treatment |
Case Studies |
Congenital rubella syndrome secondary prevention On the Web |
American Roentgen Ray Society Images of Congenital rubella syndrome secondary prevention |
Congenital rubella syndrome secondary prevention in the news |
Directions to Hospitals Treating Congenital rubella syndrome |
Risk calculators and risk factors for Congenital rubella syndrome secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]
Overview
Secondary Prevention
Once an infant has been diagnosed with congenital rubella syndrome, the following precautionary measures should be taken into account:[1]
- During the duration of the hospital stay, the infant should be isolated (i.e.: droplet and contact isolation)
- All hospital contacts and caregivers of infant with congenital rubella syndrome should be ensured that they are immune to rubella virus
- Because infants with congenital rubella syndrome are infectious for at least a period of 12 months, they may pose a risk for unimmunized children and pregnant women
- Seronegative women should be offered the MMR vaccine in the postpartum period to reduce the risk of rubella infection and congenital rubella syndrome in subsequent pregnancies.[2]
References
- ↑ Center for Disease Control and Prevention https://www.cdc.gov/vaccines/pubs/surv-manual/chpt15-crs.html. Accessed on Jan 17, 2017
- ↑ Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L (1998). "Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP)". MMWR Recomm Rep. 47 (RR-8): 1–57. PMID 9639369.